Press Releases
France’s CHRU de Nancy Joins the TriNetX Network to Strengthen Investigator-Initiated Research Output and Patient Access to Innovative Therapies
Nancy, France, May 22, 2023 — The Centre Hospitalier Régional Universitaire (CHRU) de Nancy, one of the leading research institutions in France, announced it is partnering with TriNetX to attain access to global real-world data (RWD) to generate real-world evidence...
TriNetX Publishes European Multiple Myeloma Real-World Evidence TherapyMonitor Report
TherapyMonitor Reports Offer Regulatory-Grade Insights Built Upon European Longitudinal and Representative Patient-Level Real-World Data Cambridge, MA, April 12, 2023 — TriNetX, through its wholly owned subsidiary TriNetX Oncology GmbH, announces the availability of...
TriNetX and Clinerion Unite as TriNetX and Norstella Announce Strategic Partnership
As part of the strategic partnership between Norstella and TriNetX, TriNetX will acquire Norstella’s Clinerion subsidiary. Cambridge, MA, April 4, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development...
Chrysalis Advisory and TriNetX Establish a Strategic Collaboration to Support Research Teams Across Australia and New Zealand
Cambridge, MA, February 21, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced a strategic collaboration with Chrysalis Advisory, also known as Chrysalis Health...
TriNetX Announces the Appointment of Arnaub Chatterjee as Chief Product and Solutions Officer
Cambridge, MA, February 14, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Arnaub Chatterjee has joined the company as Chief Product and Solutions Officer....
TriNetX Announces the Appointment of Shields Carstarphen as Chief Commercial Officer
Cambridge, MA, January 17, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Shields Carstarphen has joined the company as Chief Commercial Officer. “We are...